Advanced Search
Select the Categories and/or Inventors to begin filtering. To narrow search results, use the search bar for additional keywords.
Search returned 688 results
Stent Explantation Device: A Novel Solution for Safe Endovascular Graft RemovalOhman, John ; Li, Richard ; Zayed, Mohamed
T-021493
— Published date: 6/9/2026 Value Proposition: New medical device that allows for safe stent graft removal without damaging surround tissues. Technology Description Researchers at Washington University in St. Louis have developed an innovative medical device specifically designed to facilitate the…
Neurotechnology System that Utilizes Saccades to Monitor and Enhance Human CognitionLeuthardt, Eric ; Brunner, Peter ; Tan, Gansheng
T-021663
— Published date: 6/4/2026 Value Proposition: Brain-computer interface for monitoring and modulating neural states based on saccade-related neural dynamics. Technology Description Researchers at Washington University in St. Louis have developed a neurotechnology platform that monitors and modulat…
Shielded Discectomy Knife for Safer Intervertebral Disc IncisionAcland, Benjamin ; Yahanda, Alexander ; Molina, Camilo
T-021827
— Published date: 6/4/2026 Value Proposition: Novel surgical cutting tool that allows for more precise annular incisions during spinal surgeries. Technology Description Researchers at Washington University in St. Louis have developed a shielded surgical cutting instrument named the “Lysot…
Endovascular Application Method that Improves Intraluminal Penetration of Therapeutic AgentsGenin, Guy ; Roberts, Sophia ; Rucker, Devaughn ; Zemlin, Christian ; Cashin, John ; Zayed, Mohamed
T-020449
— Published date: 6/4/2026 Value Proposition: Method allowing for more effective delivery of therapeutic agents into the intima and media layers of a blood vessel. Technology Description Researchers at Washington University in St. Louis have developed a new method for utilizing electroporation an…
Potentiator that Enhances Mucociliary Transport to Treat Cystic Fibrosis and other Mucus Obstructive DiseasesBerry, Kayla ; Miller, Mark ; Nichols, Colin ; Sala-Rabanal, Monica ; Yurtsever, Zeynep ; Alexander-Brett, Jennifer ; Brett, Thomas
T-021341
— Published date: 6/3/2026 Value Proposition: Using CLCA1 VWA to specifically potentiate TMEM16A to enhance mucociliary transport in cystic fibrosis and other mucus obstructive diseases. Technology Description Researchers at Washington University in St. Louis have developed a potentiator, CLCA1 …
Novel Cell Therapy Platform for Cancer using Engineered cDC1 Dendritic CellsDeSelm, Carl
T-019199
— Published date: 6/2/2026 Value proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors. Technology Desc…
Method for Mobilizing Hematopoietic Stem Cells Using VLA4 InhibitorsRettig, Michael ; DiPersio, John ; Ruminski, Peter
T-019410
— Published date: 6/2/2026 Value Proposition: VLA4 inhibitors that significantly mobilize hematopoietic stem cells from bone marrow. Technology Description Researchers at Washington University in St. Louis have developed novel VLA4 inhibitors for mobilizing hematopoietic stem cells in peripheral …
Disease-Modifying ASO Therapy for Mitchell Syndrome and ObesitySchoch, Kathleen ; Bucelli, Robert ; Hubler, Zita ; Miller, Timothy
T-021317
— Published date: 6/2/2026 Value Proposition: First-in-class antisense oligonucleotide (ASO) therapy selectively lowering ACOX1 to enable disease-modifying treatment of Mitchell Syndrome and unlocking a metabolic shift facilitating weight loss. Technology Description: Mitchell Syndrome is an u…
A Novel Echocardiographic Parameter for Dynamic Assessment of Diastolic Function in Acute Heart FailureMay, Adam ; Davis, John
T-021708
— Published date: 5/30/2026 Value Proposition: Doppler-derived parameter that can account for the preload condition dependency of diastolic function in acute heart failure. Technology Description Researchers at Washington University in St. Louis have developed and validated the Dynamic Diastolic L…
Novel Cell Therapy Platform for Cancer using Engineered cDC1 Dendritic CellsPandey, Gaurav ; Namen, Shelby ; DeSelm, Carl
T-020903
— Published date: 5/30/2026 Value Proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors. Technology Descr…
Kidney Disease Biomarkers for Diagnosis, Prognosis or Clinical Trials MonitoringKim, Yeawon ; Chen, Ying
T-016375
— Published date: 5/29/2026 Value Proposition: Urine-based biomarkers that can be used for early detection and diagnosis of kidney disease non-invasively. Technology Description Researchers at Washington University in St. Louis have identified three sensitive, urine-based biomarkers of kidney di…
Techniques to Measure Nephron Number in the Kidney In VivoBaldelomar, Edwin ; Bennett, Kevin
T-021632
— Published date: 5/23/2026 Value Proposition: Method that uses non-contrast MRI to measure nephron number for individualized assessment of kidney functional capacity. Technology Description Researchers at Washington University in St. Louis have developed a method of using non-contrast MRI to d…
Novel Sulfated Neurosteroid Molecules for Treating Migraines and PainEvers, Alex ; Mennerick, Steven ; Zorumski, Charles ; Covey, Douglas
T-021437
— Published date: 5/23/2026 Value Proposition: Steroidal trifluoromethyl ketone modulators of GABA-A and NMDA receptors for treating migraine, headache, and pain. Technology Description Clinical and scientific experts in modulating GABA-A and NMDA receptors at Washington University in St. Louis…
Peptide Functionalized Viscoelastic Hydrogels for Scalable hiPSC Cardiac DifferentiationHashemi, Mohammad ; Huebsch, Nathaniel
T-021813
— Published date: 5/23/2026 Value Proposition: Hydrogel platform that enables scalable production of cardiomyocytes Technology Description Researchers at Washington University in St. Louis have developed a chemically defined, tunable hydrogel platform that improves the production of human induce…
New Composition of Matter that can be used to Treat Multidrug Resistant InfectionsXue, Yao-Peng ; Dantas, Gautam ; Li, Ruihao ; Wencewicz, Timothy
T-021458
— Published date: 5/23/2026 Value Proposition: Covalent mechanism-based inhibitors of tetracycline destructases for treating infectious diseases. Technology Description Researchers at Washington University in St. Louis have developed a group of C9-modified anhydrotetracyclines that inhibit tetra…
Inhibition of E. coli Hemolysin During Urinary Tract InfectionsDiamond, Michael ; Kuhn, Hunter ; Ma, Hongming ; Hunstad, David
T-020923
— Published date: 5/20/2026 Value Proposition: Potential adjunctive therapy for E. coli pyelonephritis to mitigate the renal tissue damage associated with infection, thereby reducing renal scarring and other long-term complications of renal scarring. Technology Description Researchers at Washingt…
System for Sonogenetic Control of Islet Organoids Function for Type 1 Diabetes TreatmentChen, Hong ; Cui, Jianmin
T-020579
— Published date: 5/13/2026 Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes. Technology Description Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
System for Sonogenetic Control of Islet Organoids Function for Type 1 Diabetes TreatmentCui, Jianmin
T-021674
— Published date: 5/13/2026 Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes. Technology Description Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
Novel Long Non-coding RNA for the Treatment of Colorectal CancerCabanski, Christopher ; Fields, Ryan ; Silva-Fisher, Jessica ; Maher, Christopher
T-018788
Publication date: 4/28/2026 Value Proposition: Non-coding RNA as a novel biomarker and therapeutic target for treating colon cancer. Technology Description Researchers at Washington University in St. Louis have developed a novel non-coding RNA, nam …
Diagnostic and Biomarker for Treating Atopic Dermatitis (AD)Mack, Madison ; Brestoff Parker, Jonathan ; Kim, Brian
T-018984
— Published date: 4/21/2026 Value Proposition: IL-15 superagonist that utilizes a companion diagnostic to treat atopic dermatitis. Technology Description Researchers at Washington University in St. Louis have developed a treatment strategy for atopic dermatitis that uses an IL-15 superagonist, al…
